BCRX icon

BioCryst Pharmaceuticals
BCRX

Overview Fund Trends Analyst Outlook Journalist POV

123 hedge funds and large institutions have $938M invested in BioCryst Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

9% less call options, than puts

Call options by funds: $9.82M | Put options by funds: $10.8M

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
123
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9.82M
Puts
$10.8M
Net Calls
Net Calls Change

Top Buyers

1
+$16.4M
2
+$11.3M
3
+$11.2M
4
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$8.18M
5
PA
Perceptive Advisors
New York
+$7.02M

Top Sellers

1
-$64.5M
2
-$20.5M
3
-$18M
4
Millennium Management
Millennium Management
New York
-$7.68M
5
AQR Capital Management
AQR Capital Management
Connecticut
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$5.23M
27
$4.21M
28
$4.16M
29
$3.87M
30
$3.31M
31
$3.13M
32
$2.97M
33
$2.74M
34
$2.34M
35
$2.16M
36
$2.05M
37
$1.98M
38
$1.89M
39
$1.8M
40
$1.78M
41
$1.77M
42
$1.75M
43
$1.7M
44
$1.57M
45
$1.52M
46
$1.48M
47
$1.36M
48
$1.35M
49
$1.35M
50
$1.3M
1
2
3 4 5